Anlon Healthcare Limited (NSE:AHCL)
127.03
-6.96 (-5.19%)
At close: Jan 20, 2026
Anlon Healthcare Company Description
Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally.
The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products.
Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas.
The company was incorporated in 2013 and is based in Rajkot, India.
Anlon Healthcare Limited
| Country | India |
| Founded | 2013 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 117 |
| CEO | Punitkumar Rasadia |
Contact Details
Address: 101/102-Silver Coin Complex Rajkot, Gujarat 360005 India | |
| Phone | 91 28 1256 2538 |
| Website | anlon.in |
Stock Details
| Ticker Symbol | AHCL |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Punitkumar Rasadia | Chief Executive Officer |
| Hiteshkumar Makwana | Chief Financial Officer |